Dr Claire Skentelbery, Director General of EuropaBio, has called on Central and Eastern European (CEE) biotech leaders to attend the 4th edition of the Prague.bio Conference, scheduled for 23 September 2026 in Prague. The event, which expects over 400 participants, will feature keynotes, panel discussions, workshops, and pitch sessions, with networking facilitated via a conference app. Dr Skentelbery emphasised the conference's role in connecting biotech innovators across the region.
No prior coverage of this event or related EuropaBio activities was found in EUMatrix's archives for the past 180 days. The conference aims to foster collaboration in the CEE biotech sector, which has seen growing investment and policy attention in recent years. EuropaBio, representing over 5,000 biotech companies—4,600 of which are SMEs—continues to advocate for supportive EU regulations, including the EU Biotech Act and reforms to the General Pharmaceutical Legislation. The Prague.bio Conference 2026 offers a platform for stakeholders to discuss challenges and opportunities, from biomanufacturing to sustainable innovations like algal omega-3 and enzyme-based detergents.
← Atlas › News › Industry, Innovation and Internal Market